T
INSM icon

TCWP’s Insmed INSM Stock Holding History

TCWP’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-106
Closed -$2K – 972
2022
Q1 		$2K Buy
+106
New +$2.46K ﹤0.01% 1331

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

TCWP's INSM Position: Q2 2022 in Review

TCWP sold out of Insmed (INSM) in Q2 2022, closing a stake of 106 shares — an estimated $2K sold.

TCWP first reported a position in INSM in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 214 funds tracked by Wall St. Rank hold INSM as of Q2 2022.

  • TCWP reported no remaining Insmed position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 106 Insmed shares in Q2 2022, an estimated $2K.
  • TCWP first reported a position in Insmed in Q1 2022 and held it in 1 quarter.
  • TCWP's Insmed position peaked at $2K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.